BE723905A - - Google Patents

Info

Publication number
BE723905A
BE723905A BE723905DA BE723905A BE 723905 A BE723905 A BE 723905A BE 723905D A BE723905D A BE 723905DA BE 723905 A BE723905 A BE 723905A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE723905A publication Critical patent/BE723905A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01RELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R33/00Coupling devices specially adapted for supporting apparatus and having one part acting as a holder providing support and electrical connection via a counterpart which is structurally associated with the apparatus, e.g. lamp holders; Separate parts thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
BE723905D 1967-11-17 1968-11-14 BE723905A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1610167A CH510655A (de) 1967-11-17 1967-11-17 Verfahren zur Herstellung neuer Halogenpregnadiene

Publications (1)

Publication Number Publication Date
BE723905A true BE723905A (en:Method) 1969-05-14

Family

ID=4414467

Family Applications (1)

Application Number Title Priority Date Filing Date
BE723905D BE723905A (en:Method) 1967-11-17 1968-11-14

Country Status (15)

Country Link
US (1) US3652554A (en:Method)
JP (1) JPS4829221B1 (en:Method)
AT (3) AT298695B (en:Method)
BE (1) BE723905A (en:Method)
BR (1) BR6804024D0 (en:Method)
CH (4) CH540244A (en:Method)
DK (1) DK129835B (en:Method)
FR (2) FR1594773A (en:Method)
GB (1) GB1245292A (en:Method)
MY (1) MY7400317A (en:Method)
NL (1) NL161767C (en:Method)
PL (1) PL80570B1 (en:Method)
SE (1) SE351634B (en:Method)
SU (1) SU424352A3 (en:Method)
YU (4) YU34138B (en:Method)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2010458B2 (de) * 1970-02-28 1979-04-26 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue 21-Halogensteroide
CH558787A (de) * 1970-12-10 1975-02-14 Ciba Geigy Ag Verfahren zur herstellung eines neuen halogenpregnadiens.
GB1377608A (en) * 1970-12-17 1974-12-18 Glaxo Lab Ltd 3alpha-hydroxy or acyloxy pregnene-21-ethers
NL7502252A (nl) * 1974-02-27 1975-08-29 Pierrel Spa Werkwijze voor het bereiden van een geneesmid- del met anti-inflammatoire werking, gevormd ge- neesmiddel verkregen volgens deze werkwijze alsmede werkwijze voor het bereiden van in het geneesmiddel gebruikte nieuwe steroiden.
DE2512915A1 (de) * 1974-03-27 1975-10-09 Plurichemie Anstalt 16-methyl-9 alpha-halogen-steroide ester, aether und verfahren zu ihrer herstellung
GB1505701A (en) * 1975-06-14 1978-03-30 Pierrel Spa 2-chloro-6beta-fluoropregnanes
FR2291760A1 (fr) * 1974-11-19 1976-06-18 Pierrel Spa Nouveaux steroides a base de 2-chloro-6 b-fluoro-pregna-1,4-diene-3,20-diones
DE2655570A1 (de) * 1975-12-12 1977-06-16 Ciba Geigy Ag Neue polyhalogensteroide und verfahren zu ihrer herstellung
WO2005021515A2 (en) * 2003-08-29 2005-03-10 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
CA2626628A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
WO2008035315A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
CN103497185A (zh) 2007-03-14 2014-01-08 兰贝克赛实验室有限公司 用作磷酸二酯酶抑制剂的吡唑并(3,4-b)吡啶衍生物
EP2124943A1 (en) * 2007-03-14 2009-12-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN102827229B (zh) * 2011-06-17 2016-01-20 重庆华邦胜凯制药有限公司 一种纯化卤米松羧酸酯的方法
CN104370987B (zh) * 2014-10-22 2016-09-14 湖南明瑞制药有限公司 一种卤米松的精制方法
CN111944004B (zh) * 2020-09-25 2023-11-17 湖南新合新生物医药有限公司 一种卤米松的制备方法

Also Published As

Publication number Publication date
SE351634B (en:Method) 1972-12-04
YU30875A (en) 1982-05-31
US3652554A (en) 1972-03-28
CH540244A (de) 1973-08-15
YU30775A (en) 1982-05-31
YU34138B (en) 1978-12-31
AT298695B (de) 1972-05-25
YU30675A (en) 1982-05-31
PL80570B1 (en:Method) 1975-08-30
SU424352A3 (en:Method) 1974-04-15
DK129835B (da) 1974-11-25
AT293633B (de) 1971-10-25
FR1594773A (en:Method) 1970-06-08
CH513845A (de) 1971-10-15
JPS4829221B1 (en:Method) 1973-09-08
MY7400317A (en) 1974-12-31
GB1245292A (en) 1971-09-08
BR6804024D0 (pt) 1973-01-02
CH510655A (de) 1971-07-31
DE1807980A1 (de) 1969-06-04
DE1807980B2 (de) 1975-11-06
FR8278M (en:Method) 1970-11-02
NL161767C (nl) 1980-03-17
NL6816337A (en:Method) 1969-05-20
DK129835C (en:Method) 1975-05-05
CH534144A (de) 1973-02-28
YU267368A (en) 1978-06-30
AT298690B (de) 1972-04-15

Similar Documents

Publication Publication Date Title
BE705551A (en:Method)
AU2528767A (en:Method)
AU2977667A (en:Method)
AU3151267A (en:Method)
BE696739A (en:Method)
AU25066A (en:Method)
AU34866A (en:Method)
BE692332A (en:Method)
BE692779A (en:Method)
BE692922A (en:Method)
BE693075A (en:Method)
BE693675A (en:Method)
BE695079A (en:Method)
BE696163A (en:Method)
BE709079A (en:Method)
BE697364A (en:Method)
BE698191A (en:Method)
BE698220A (en:Method)
BE698336A (en:Method)
BE698439A (en:Method)
BE698676A (en:Method)
BE699227A (en:Method)
BE699837A (en:Method)
BE700003A (en:Method)
BE700504A (en:Method)

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: CIBA S.A.

Effective date: 19871130